Why is "Angioedema" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-20 00:54:21
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Angioedema is an area of swelling (edema) of the lower layer of skin and tissue just under the skin or mucous membranes. The swelling may occur in the face, tongue, larynx, abdomen, or arms and legs. Often it is associated with hives, which are swelling within the upper skin. Onset is typically over minutes to hours.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
A Cautionary Tale: Urticaria and Angioedema As Presenting Signs of Lymphoproliferative Disorders - Cureus
-
Unraveling angioedema: diagnostic challenges and emerging therapies - Frontiers
-
3 cases of hereditary angioedema linked to the same sperm donor, the first documented - apd.cat
-
Expanding Access to Angioedema Treatment in Jordan - Anera
-
New Guidelines Shift Hereditary Angioedema Treatment Strategy - HCPLive
-
Hereditary Angioedema Market Set to Boom Rapidly, Witnessing - openPR.com
-
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026 - Intellia Therapeutics
-
Differentiating Hereditary Angioedema From Its Mimics - HMP Global Learning Network
-
KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference - Business Wire
-
Validating the Angioedema Control Test: A New Objective Anchor for HAE Care - Physician's Weekly
-
Hereditary Angioedema: Clinical Decision-Making and Emerging Therapies - Medscape
-
As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation? - BioSpace
-
Ecological momentary assessments for patients with hereditary angioedema: a feasibility and acceptability controlled study - Frontiers
-
Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Presenting After Long-Term Antihypertensive Therapy: A Case Report - Cureus
-
Implementation of Genetic Diagnosis and Personalized Management of Hereditary Angioedema in a Chinese Regional Center: A Community Case Study of Three Families - Frontiers
-
Labial Angioedema and Bacterial and Viral Infection Following Hyaluronic Acid Injection - Cureus
-
Cardiac and vascular autonomic control in patients with hereditary angioedema - Frontiers
-
Unusual Presentation of Odontogenic Cellulitis Mimicking Drug-Induced Angioedema: A Case Report - Cureus
-
Editorial: Genetic and immunological insights into angioedema without wheals - Frontiers
-
Disease control and disease activity in hereditary angioedema: two sides of the same coin? - Frontiers
-
Pharvaris N.V. (PHVS) Presents at 2026 Global Angioedema Leadership Conference - Slideshow - Seeking Alpha
-
Beyond the Brackets: A Case Report of Acute Angioedema Associated With Orthodontic Treatment - Cureus
-
Exercising With HAE: Benefits, Risks, and Safety Strategies - Everyday Health
-
VIDEO: Distinguishing between different forms of angioedema key to effective treatment - Healio
-
Blood pressure medication causes rare life-threatening reaction after 11 years - Angioedema News
-
Hereditary Angioedema in Women: Special Considerations for Prevention and Care - Everyday Health
-
Intellia Advances Gene Editing Programs Toward Hereditary Angioedema Commercial Reality - Yahoo Finance
-
Thrombolysis‑Induced Orolingual Angioedema Ups Tracheostomy Risk - Physician's Weekly
-
Dawnzera Approved to Prevent Hereditary Angioedema Attacks - Medical Professionals Reference
-
Lisinopril-Induced Angioedema Triggered by Tattoo Cellulitis and Acute Kidney Injury: A Case Report - Cureus
-
Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema - Cureus
-
One-time infusion well tolerated, lowers monthly hereditary angioedema attack rate - Healio
-
New Research Highlights Care Challenges Faced by Children and Adolescents with Hereditary Angioedema - American College of Allergy Asthma and Immunology
-
Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention - PharmaTimes
-
Obesity Associated With Later CSU Onset, Reduced Therapy Response - AJMC
-
Tranexamic acid falls short in ACEI-induced angioedema study - Angioedema News
-
A lived example helped me better understand my daughter with HAE - Angioedema News
-
Improved Disease Control After Prophylactic Switching in Hereditary Angioedema - Physician's Weekly
-
Manage the Stress of Hereditary Angioedema: Tips for Relief and Prevention - Everyday Health
-
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S - Wiley Online Library
-
Clinical Features| Hereditary Angioedema - Healio
-
Childhood hereditary angioedema worries, interrupts lives of patients, caregivers - Healio
-
What Should You Eat if You Have Hereditary Angioedema? - Everyday Health
-
Eosinophilic inflammation in hereditary angioedema: a single-center real-world retrospective chart review study - Frontiers
-
COVID-19–Induced Flare of Hereditary Angioedema in a Twelve-Year-Old Female Patient - Cureus
-
People’s Pharmacy: ACE inhibitors can occasionally cause angioedema. What should you do if you see this side - OregonLive.com
-
One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency - Frontiers
-
Otsuka gains EU approval of RNA-targeting preventative for hereditary angioedema - FirstWord Pharma
-
Expanding access to hereditary angioedema care in Vietnam - Takeda Pharmaceuticals
-
FDA Approves First RNA-Targeted Treatment for Hereditary Angioedema - AJMC
-
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference - Business Wire
-
Fact or Fiction: Hereditary Angioedema - Medscape Reference
-
BioCryst’s First Profitable Year Recasts Hereditary Angioedema Growth Story - Yahoo Finance
-
JAA - Dove Medical Press
-
A new genomic technique reveals a previously undetectable genetic alteration in hereditary angioedema - Hospital Universitari Vall d'Hebron
-
Generalized Rash and Angioedema During Triple Antiepileptic Therapy: A Case Report - Cureus
-
ICU Admission for Angioedema Often Unnecessary & Prolongs LOS - Physician's Weekly
-
FDA Approves Sebetralstat for Hereditary Angioedema - AJMC
-
Ionis to present new data supporting DAWNZERA™ (donidalorsen) in hereditary angioedema at 2026 AAAAI Annual Meeting - BioSpace
-
Berotralstat Becomes First Oral Prophylactic for Pediatric Patients With Hereditary Angioedema - Pharmacy Times
-
DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE) - Business Wire
-
FDA approves berotralstat for patients aged 2 to 11 years with hereditary angioedema - Contemporary Pediatrics
-
Pharvaris Announces Positive Phase 2 Study Results for Deucrictibant in Hereditary Angioedema Management - Quiver Quantitative
-
FDA Approves Garadacimab-gxii in Hereditary Angioedema - AJMC
-
Intestinal Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Diagnosis of Exclusion - Cureus
-
VIDEO: Insurance ‘biggest barrier to care’ in hereditary angioedema - Healio
-
Hereditary Angioedema Market to Hit USD 5.96 Billion in 2032 | Coherent Market Insights - BioSpace
-
FDA approves garadacimab-gxii as prophylaxis for hereditary angioedema - Healio
-
Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress - Intellia Therapeutics
-
Guideline Recommendations | Hereditary Angioedema - Healio
-
Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema - Yahoo Finance
-
Managing Hereditary Angioedema with Normal C1 Inhibitor - European Medical Journal
-
FDA approves Ionis drug that prevents swelling attacks caused by a rare disease - statnews.com
-
Long-term Prophylaxis| Hereditary Angioedema - Healio
-
Subcutaneous C1-INH Improves Life with Hereditary Angioedema - European Medical Journal
-
Acquired angioedema may be first sign of underlying lymphoma - Angioedema News
-
FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema - Pharmacy Times
-
KalVista’s Ekterly for Hereditary Angioedema Attacks Approved by FDA - Inside Precision Medicine
-
Hereditary Angioedema Treatments and Common Side Effects, Explained - Cleveland Clinic Health Essentials
-
Effectiveness of Berotralstat▼ for Hereditary Angioedema Prophylaxis - European Medical Journal
-
Unilateral Tongue and Lip Edema: A Rare Presentation of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema - Cureus
-
Dawnzera: First RNA-Targeted Therapy to Prevent Hereditary Angioedema Attacks - WebMD
-
Rare HAE diagnosis explains years of severe abdominal pain in man - Angioedema News
-
Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema of the Small Bowel: A Diagnostic Dilemma - Journal of the American Board of Family Medicine
-
A Two-Decade-Delayed Diagnosis of Hereditary Angioedema: A Case Report - Cureus
-
FDA Approves Oral Ekterly for On-Demand Hereditary Angioedema Treatment - MPR - Medical Professionals Reference
-
Barely There But Existent: Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema - Cureus
-
Pharvaris clocks a pivotal win in race for rapid HAE relief, teeing up filing to challenge KalVista - Fierce Biotech
-
Neutrophilic Urticarial Dermatosis With Angioedema: A Diagnostic and Therapeutic Challenge - Cureus
-
Tranexamic Acid Use in ACE Inhibitor-Induced Angioedema Outcomes - Physician's Weekly
-
DAWNZERA (donidalorsen) approved in the U.S. as first and only RNA-targeted prophylactic treatment for hereditary angioedema - Business Wire
-
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe - Business Wire
-
FDA approves Ionis’ hereditary angioedema drug - BioPharma Dive
-
A Swollen Dilemma: A Case Report of Concurrent Periorbital Cellulitis and Angioedema - Cureus
-
Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema - Zacks Investment Research
-
HAS Rejects Post-MA Early Access Request for Ekterly in Hereditary Angioedema Treatment - NAVLIN DAILY
-
KalVista Pharmaceuticals Presents New Data Highlighting the Potential of EKTERLY® (sebetralstat) to Transform On-Demand Hereditary Angioedema Treatment in Europe - Yahoo Finance
-
Angiotensin-Converting Enzyme Inhibitor (ACEI)-Induced Angioedema After Re-exposure to Lisinopril: A Case Report and Clinical Review - Cureus
-
KalVista Announces Positive Interim Data for Hereditary Angioedema Drug - National Today
-
CSL Wins First Approval for Preventive Hereditary Angioedema Drug - BioSpace
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.